During the past decade, Preferred Research Partners, Inc conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 36 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 29 clinical trials were completed. i.e. 107.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Preferred Research Partners, Inc" #1 sponsor was "Allergan" with 6 trials, followed by "Phathom Pharmaceuticals, Inc." with 5 trials sponsored, "Ferring Pharmaceuticals" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Preferred Research Partners, Inc" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Preferred Research Partners, Inc" are "Obstructive Sleep Apnea" (7 trials), "Chronic Idiopathic Constipation" (5 trials), "Gastroparesis" (5 trials), "Diabetes Mellitus" (4 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials). Many other conditions were trialed in "Preferred Research Partners, Inc" in a lesser frequency.

Most popular intervention types in "Preferred Research Partners, Inc" are "Drug" (58 trials), "Other" (6 trials), "Biological" (3 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Vonoprazan" (5 trials), "Relamorelin" (4 trials), "Daridorexant 25 mg" (3 trials) and "Daridorexant 50 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Preferred Research Partners, Inc" are 62 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Preferred Research Partners, Inc". undefined are not yet recruiting, 11 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Preferred Research Partners, Inc, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Preferred Research Partners, Inc, 4 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".